Skip to main navigation Skip to search Skip to main content

Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

  • WW Huinink
  • , B Bergman
  • , A Chemaissani
  • , W Dornoff
  • , P Drings
  • , P Kellokumpu-Lehtinen
  • , K Liippo
  • , K Mattson
  • , J von Pawel
  • , S Ricci
  • , C Sederholm
  • , RA Stahel
  • , G Wagenius
  • , NV Walree
  • , C Manegold

    Research output: Contribution to journalArticleScientificpeer-review

    71 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)85-94
    JournalLung Cancer
    Volume26
    Issue number2
    Publication statusPublished - 1999
    Publication typeA1 Journal article-refereed

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this